| Ausstehende Aktien | 11,617,250 shares |
| Insider-Aktien | 102.563.537 shares |
| Insider gesamt | 19 |
Insider-Stimmungswert
Der Insider-Stimmungswert ermittelt die Unternehmen, die von Unternehmensinsidern gekauft werden.
Es ist das Ergebnis eines ausgeklügelten quantitativen Multifaktormodells, das die Unternehmen mit der höchsten Insiderakkumulation identifiziert. Das Scoring-Modell verwendet eine Kombination aus der Nettozahl der Insiderkäufe der letzten 90 Tage, der Gesamtzahl der gekauften Aktien als Prozentsatz des Streubesitzes und der Gesamtzahl der von Insidern gehaltenen Aktien. Die Zahl reicht von 0 bis 100, wobei höhere Zahlen ein höheres Maß an Insiderkäufen anzeigen als bei anderen Unternehmen und 50 den Durchschnitt darstellt.
Aktualisierungshäufigkeit: Täglich
Führungskräfte-Stimmungswert
Der Führungskräfte-Stimmungswert findet Unternehmen, die von Führungskräften des Unternehmens gekauft werden.
Per Definition sind Führungskräfte des Unternehmens Insider, aber im Gegensatz zu anderen Insidern (10%ige Aktionäre und Vorstandsmitglieder) arbeiten Führungskräfte täglich für das Unternehmen und verwenden beim Handel ihr eigenes Geld. (10%ige Aktionäre und Vorstandsmitglieder sind oft Fondsmanager, die das Geld anderer Leute verwalten.) Daher sind Insider-Geschäfte, die von Führungskräften getätigt werden, viel bedeutender und sollten entsprechend behandelt werden.
Wie der Insider-Stimmungswert ist auch der Führungskräfte-Stimmungswert das Ergebnis eines ausgeklügelten quantitativen Multifaktormodells, das die Unternehmen mit der höchsten Führungskräftekonzentration identifiziert.
Aktualisierungshäufigkeit: Täglich
Wichtige Insider-Kennzahlen
Diese Karte zeigt, wie das Unternehmen bei verschiedenen Insider-Kennzahlen abschneidet. Der Perzentil-Rang zeigt, wie dieses Unternehmen im Vergleich zu anderen Unternehmen auf den US-Märkten abschneidet. Höhere Ränge deuten auf eine bessere Situation hin.
Es ist beispielsweise allgemein anerkannt, dass Insiderkäufe ein positiver Indikator sind, so dass Unternehmen mit mehr Insiderkäufen besser abschneiden würden als Unternehmen mit weniger Insiderkäufen (oder sogar Insiderverkäufen).
Prozent des Streubesitzes von Insidern gekauft (Rang)
8994 out of 10752
Prozent des von Insidern gekauften Streubesitzes ist die Gesamtzahl der von Insidern gekauften Aktien abzüglich der Gesamtzahl der von Insidern in den letzten 90 Tagen verkauften Aktien, geteilt durch den gesamten Streubesitz und multipliziert mit 100.
Diagramm zum Insiderhandel
Phio Pharmaceuticals Corp. Insider-Trades sind in der folgenden Grafik dargestellt. Insider sind leitende Angestellte, Direktoren oder bedeutende Investoren in einem Unternehmen. Im Allgemeinen ist es für Insider illegal, auf der Grundlage von wesentlichen, nicht-öffentlichen Informationen mit Aktien ihrer Unternehmen zu handeln. Das bedeutet nicht, dass es für sie illegal ist, irgendwelche Geschäfte in ihren eigenen Unternehmen zu tätigen. Sie müssen jedoch alle Geschäfte der SEC über ein Formular 4 melden.
Kennzahlen zu Insiderlisten und Rentabilität
Diese Tabelle zeigt die Liste der bekannten Insider und wird automatisch aus den bei der SEC eingereichten Unterlagen erstellt. Zusätzlich zu den Namen, dem letzten Titel und der Bezeichnung als Direktor, leitender Angestellter oder 10%-iger Anteilseigner geben wir die zuletzt veröffentlichten Bestände an. Zusätzlich stellen wir, wenn möglich, die historische Handelsperformance für den Insider zur Verfügung. Die historische Handelsperformance ist ein gewichteter Durchschnitt der Performance tatsächlicher offener Kauftransaktionen, die von dem Insider getätigt wurden. Weitere Informationen zur Berechnung dieses Wertes finden Sie in diesem YouTube-Webinar.
See our leaderboard of most profitable insider traders.
| Insider | Durchschnittlicher Gewinn (%) | Aktien in Besitz |
Split Angepasst |
|---|---|---|---|
| Advanced RNA Technologies, LLC - | 1.221.723 | 1.221.723 | |
| Patricia A Bradford Director - [D] | 45.651 | 45.651 | |
| John A Barrett Chief Development Officer - [O] | 222.991 | 8.802 | |
| Robert J Bitterman Chairman, Pres. & CEO, Director - [D] [O] | 411.421 | 411.421 | |
| Keith L Brownlie Director - [D] | 20.000 | 789 | |
| Geert Cauwenbergh Director - [D] | 4.235 | 471 |
| Insider | Durchschnittlicher Gewinn (%) | Aktien in Besitz |
Split Angepasst |
|---|---|---|---|
| Lisa Cabott Carson Chief Financial Officer - [O] | 94.000 | 94.000 | |
| David H Deming Director - [D] | 37.800 | 37.800 | |
| Gerrit Dispersyn President & CEO, Director - [D] [O] | 212.327 | 20.222 | |
| Dorman H. Paul Director - [D] | 20.370 | 1.940 | |
| Alexey Eliseev Chief Business Officer - [O] | 950.312 | 950.312 | |
| Robert L Ferrara Director - [D] | 38.766 | 38.766 |
| Insider | Durchschnittlicher Gewinn (%) | Aktien in Besitz |
Split Angepasst |
|---|---|---|---|
| Jonathan E Freeman Director - [D] | 32.655 | 32.655 | |
|
Galena Biopharma, Inc.
10% Owner -
|
32.393.095 | 32.393.095 | |
| Infarinato Robert M. VP, CFO - [O] | 11.000 | 11.000 | |
| Caitlin Kontulis Secretary & VP Finance & Admin - [O] | 10.643 | 1.183 | |
| Curtis Lockshin Director - [D] | 35.155 | 35.155 | |
|
Opko Health, Inc.
10% Owner -
|
67.241.380 | 67.241.380 | |
| Pamela Pavco Chief Development Officer - [O] | 17.173 | 17.173 |
Report errors via our new Insider Auditing Tool
Erfolgsbilanz der Insiderkäufe - Kurzfristige Gewinnanalyse
In diesem Abschnitt analysieren wir die Rentabilität jedes ungeplanten Insiderkaufs, der auf dem freien Markt in PHIO / Phio Pharmaceuticals Corp. getätigt wurde. Diese Analyse hilft zu verstehen, ob der Insider beständig abnormale Renditen erzielt und es sich lohnt, ihm zu folgen. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch .
Die folgende Tabelle zeigt die jüngsten Käufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
Bereinigter Preis ist der splitbereinigte Preis. Bereinigte Aktien sind die um den Split bereinigten Aktien.
Erfolgsbilanz von Insiderverkäufen - Kurzfristige Verlustanalyse
In diesem Abschnitt analysieren wir die kurzfristige Verlustvermeidung jedes ungeplanten Insider-Verkaufs auf dem freien Markt in PHIO / Phio Pharmaceuticals Corp.. Ein konsistentes Muster der Verlustvermeidung kann darauf hindeuten, dass zukünftige Verkaufstransaktionen Kursrückgänge vorhersagen können. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch .
Die folgende Tabelle zeigt die jüngsten Verkäufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
Bereinigter Preis ist der splitbereinigte Preis. Bereinigte Aktien sind die um den Split bereinigten Aktien.
Transaktionshistorie
Klicken Sie auf das Link-Symbol, um den vollständigen Transaktionsverlauf anzuzeigen. Transaktionen, die im Rahmen eines automatischen Handelsplans 10b5-1 gemeldet werden, sind in der Spalte 10b-5 mit einem X gekennzeichnet.
| Datei Datum |
Handel Datum |
Form | Insider | Ticker | Wertpapier-Titel | Code | Direkt | Ausführung Preis |
Einheit Preis |
Eimheiten Verändert |
Wert Geändert (1K) |
Verbleibende Optionen |
Verbleibende Aktien |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-06 | 2026-02-05 | 4 | Freeman Jonathan E | PHIO | Common Stock, $.0001 par value | D | 16.600 | 32.655 | ||||||
| 2026-02-06 | 2026-02-05 | 4 | Lockshin Curtis | PHIO | Common Stock, $.0001 par value | D | 16.600 | 35.155 | ||||||
| 2026-02-06 | 2026-02-05 | 4 | Carson Lisa Cabott | PHIO | Common Stock, $.0001 par value | D | 47.000 | 94.000 | ||||||
| 2026-02-06 | 2026-02-05 | 4 | Deming David H | PHIO | Common Stock, $.0001 par value | D | 23.800 | 37.800 | ||||||
| 2026-02-06 | 2026-02-05 | 4 | BRADFORD PATRICIA A | PHIO | Common Stock, $.0001 par value | D | 18.500 | 45.651 | ||||||
| 2026-02-06 | 2026-02-05 | 4 | Bitterman Robert J | PHIO | Common Stock, $.0001 par value | D | 120.000 | 411.421 | ||||||
| 2026-01-02 | 2025-12-31 | 4 | Bitterman Robert J | PHIO | Common Stock, $.0001 par value | D | 1,0300 | 5.000 | 5 | 291.421 | ||||
| 2025-12-29 | 2025-12-23 | 4 | Bitterman Robert J | PHIO | Common Stock, $.0001 par value | D | 1,0200 | 5.000 | 5 | 286.421 | ||||
| 2025-11-24 | 2025-11-21 | 4 | Bitterman Robert J | PHIO | Common Stock, $.0001 par value | D | 1,1400 | 5.000 | 6 | 281.421 | ||||
| 2025-11-19 | 2025-11-18 | 4 | Bitterman Robert J | PHIO | Common Stock, $.0001 par value | D | 1,2700 | 5.000 | 6 | 276.421 | ||||
| 2025-09-15 | 2025-09-11 | 4/A | Ferrara Robert L | PHIO | Common Stock, $.0001 par value | D | 23.100 | 38.766 | ||||||
| 2025-09-15 | 2025-09-11 | 4 | Deming David H | PHIO | Common Stock, $.0001 par value | D | 14.000 | 14.000 | ||||||
| 2025-09-15 | 2025-09-11 | 4 | Ferrara Robert L | PHIO | Common Stock, $.0001 par value | D | 23.000 | 38.666 | ||||||
| 2025-09-15 | 2025-09-11 | 4 | Freeman Jonathan E | PHIO | Common Stock, $.0001 par value | D | 14.700 | 16.055 | ||||||
| 2025-09-15 | 2025-09-11 | 4 | Lockshin Curtis | PHIO | Common Stock, $.0001 par value | D | 16.200 | 18.555 | ||||||
| 2025-09-15 | 2025-09-11 | 4 | BRADFORD PATRICIA A | PHIO | Common Stock, $.0001 par value | D | 18.800 | 27.151 | ||||||
| 2025-09-15 | 2025-09-11 | 4 | Carson Lisa Cabott | PHIO | Common Stock, $.0001 par value | D | 47.000 | 47.000 | ||||||
| 2025-09-15 | 2025-09-11 | 4 | Bitterman Robert J | PHIO | Common Stock, $.0001 par value | D | 250.000 | 271.421 | ||||||
| 2025-09-15 | 2025-09-11 | 4 | Bitterman Robert J | PHIO | Common Stock, $.0001 par value | D | 2,3200 | -4.111 | -10 | 21.421 | ||||
| 2025-06-11 | 2025-06-10 | 4 | Ferrara Robert L | PHIO | Common stock, $0.0001 par value | D | 2,4199 | 2.500 | 6 | 15.666 | ||||
| 2025-06-11 | 2025-06-10 | 4 | Bitterman Robert J | PHIO | Common Stock, $0.0001 par value | D | 2,4200 | 2.000 | 5 | 27.149 | ||||
| 2025-06-10 | 2025-06-09 | 4 | Bitterman Robert J | PHIO | Common Stock, $0.0001 par value | D | 2,7500 | 1.500 | 4 | 25.149 | ||||
| 2025-05-23 | 2025-05-22 | 4 | Bitterman Robert J | PHIO | Common Stock, $0.0001 par value | D | 1,7799 | 1.200 | 2 | 23.649 | ||||
| 2025-05-23 | 2025-05-21 | 4 | Bitterman Robert J | PHIO | Common Stock, $0.0001 par value | D | 1,7700 | 3.000 | 5 | 22.449 | ||||
| 2025-05-21 | 2025-05-20 | 4 | Ferrara Robert L | PHIO | Common stock, $0.0001 par value | D | 1,8200 | 2.500 | 5 | 13.166 | ||||
| 2024-09-13 | 2024-09-11 | 4 | Bitterman Robert J | PHIO | Common Stock, $0.0001 par value | D | 15.500 | 17.832 | ||||||
| 2024-09-13 | 2024-09-11 | 4 | Freeman Jonathan E | PHIO | Common Stock, $0.0001 par value | D | 1.000 | 1.000 | ||||||
| 2024-09-13 | 2024-09-11 | 4 | Infarinato Robert M. | PHIO | Common Stock, $0.0001 Par Value | D | 3.000 | 11.000 | ||||||
| 2024-09-12 | 2024-09-11 | 4 | Lockshin Curtis | PHIO | Common Stock, $0.0001 par value | D | 2.000 | 2.000 | ||||||
| 2024-09-12 | 2024-09-11 | 4 | BRADFORD PATRICIA A | PHIO | Common Stock, $0.0001 par value | D | 8.000 | 8.000 | ||||||
| 2024-09-12 | 2024-09-11 | 4 | Ferrara Robert L | PHIO | Common stock, $0.0001 par value | D | 10.000 | 10.000 | ||||||
| 2024-08-15 | 2024-08-13 | 4 | Infarinato Robert M. | PHIO | Common stock, $0.0001 par value | D | 8.000 | 8.000 | ||||||
| 2024-06-11 | 2024-06-07 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 0,7400 | 1.000 | 1 | 20.990 | ||||
| 2024-06-10 | 2024-06-06 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 0,7500 | 1.000 | 1 | 19.990 | ||||
| 2024-03-05 | 2024-03-01 | 4 | Kontulis Caitlin | PHIO | Common stock, $0.0001 par value | D | 0,9580 | -335 | -0 | 10.643 | ||||
| 2024-02-27 | 2024-02-26 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 0,9100 | 2.500 | 2 | 18.990 | ||||
| 2024-02-22 | 2024-02-20 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 0,7600 | -1.804 | -1 | 16.490 | ||||
| 2024-02-20 | 2024-02-17 | 4 | Kontulis Caitlin | PHIO | Common stock, $0.0001 par value | D | 0,6600 | -523 | -0 | 10.978 | ||||
| 2024-02-20 | 2024-02-15 | 4 | Kontulis Caitlin | PHIO | Common stock, $0.0001 par value | D | 0,6500 | -658 | -0 | 11.501 | ||||
| 2023-10-03 | 2023-10-01 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 1,5100 | -917 | -1 | 18.294 | ||||
| 2023-07-05 | 2023-07-01 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 2,8400 | 1.000 | 3 | 19.211 | ||||
| 2023-07-05 | 2023-06-30 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 2,8800 | 1.000 | 3 | 18.211 | ||||
| 2023-06-15 | 2023-06-14 | 4 | Ferrara Robert L | PHIO | Common stock, $0.0001 par value | D | 3,1000 | 2.000 | 6 | 6.000 | ||||
| 2023-03-03 | 2023-03-01 | 4 | Kontulis Caitlin | PHIO | Common stock, $0.0001 par value | D | 5,4900 | -335 | -2 | 12.159 | ||||
| 2023-02-22 | 2023-02-17 | 4 | Lockshin Curtis | PHIO | Common stock, $0.0001 par value | D | 1.500 | 3.197 | ||||||
| 2023-02-22 | 2023-02-17 | 4 | BRADFORD PATRICIA A | PHIO | Common stock, $0.0001 par value | D | 1.500 | 3.167 | ||||||
| 2023-02-22 | 2023-02-20 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 11.000 | 17.211 | ||||||
| 2023-02-22 | 2023-02-17 | 4 | Ferrara Robert L | PHIO | Common stock, $0.0001 par value | D | 1.500 | 4.000 | ||||||
| 2023-02-22 | 2023-02-17 | 4 | CAUWENBERGH GEERT | PHIO | Common stock, $0.0001 par value | D | 1.500 | 4.235 | ||||||
| 2023-02-22 | 2023-02-17 | 4 | Kontulis Caitlin | PHIO | Common stock, $0.0001 par value | D | 4.500 | 12.494 | ||||||
| 2023-02-22 | 2023-02-17 | 4 | Freeman Jonathan E | PHIO | Common stock, $0.0001 par value | D | 1.500 | 3.197 | ||||||
| 2023-02-17 | 2023-02-15 | 4 | Kontulis Caitlin | PHIO | Common stock, $0.0001 par value | D | 5,2000 | -657 | -3 | 7.994 | ||||
| 2022-12-15 | 2022-12-14 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 0,3900 | 2.000 | 1 | 74.541 | ||||
| 2022-12-08 | 2022-12-07 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 0,3900 | 2.000 | 1 | 72.541 | ||||
| 2022-12-06 | 2022-12-05 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 0,4300 | 2.000 | 1 | 70.541 | ||||
| 2022-12-05 | 2022-12-02 | 4 | Ferrara Robert L | PHIO | Common stock, $0.0001 par value | D | 0,4082 | 5.000 | 2 | 30.000 | ||||
| 2022-11-29 | 2022-11-29 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 0,4000 | 215 | 0 | 68.541 | ||||
| 2022-11-29 | 2022-11-25 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 0,4200 | 2.500 | 1 | 68.326 | ||||
| 2022-11-28 | 2022-11-23 | 4 | Ferrara Robert L | PHIO | Common stock, $0.0001 par value | D | 0,4099 | 2.000 | 1 | 25.000 | ||||
| 2022-11-16 | 2022-11-16 | 4 | Bitterman Robert J | PHIO | Series D Preferred Stock, $0.0001 par value | D | 1.750,0000 | 1 | 2 | 1 | ||||
| 2022-10-03 | 2022-10-01 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 40.000 | 65.826 | ||||||
| 2022-09-26 | 2022-08-09 | 4 | BRADFORD PATRICIA A | PHIO | Common stock, $0.0001 par value | D | 20.000 | 20.000 | ||||||
| 2022-03-03 | 2022-03-01 | 4 | Kontulis Caitlin | PHIO | Common stock, $0.0001 par value | D | 0,8210 | -4.011 | -3 | 103.815 | ||||
| 2022-03-03 | 2022-03-01 | 4 | Dispersyn Gerrit | PHIO | Common stock, $0.0001 par value | D | 0,8210 | -8.954 | -7 | 212.327 | ||||
| 2022-02-16 | 2022-02-15 | 4 | Lockshin Curtis | PHIO | Common stock, $0.0001 par value | D | 10.000 | 20.366 | ||||||
| 2022-02-16 | 2022-02-15 | 4 | Kontulis Caitlin | PHIO | Common stock, $0.0001 par value | D | 68.000 | 107.826 | ||||||
| 2022-02-16 | 2022-02-15 | 4 | Freeman Jonathan E | PHIO | Common stock, $0.0001 par value | D | 10.000 | 20.364 | ||||||
| 2022-02-16 | 2022-02-15 | 4 | Ferrara Robert L | PHIO | Common stock, $0.0001 par value | D | 10.000 | 23.000 | ||||||
| 2022-02-16 | 2022-02-15 | 4 | Dorman H. Paul | PHIO | Common stock, $0.0001 par value | D | 10.000 | 20.370 | ||||||
| 2022-02-16 | 2022-02-15 | 4 | Dispersyn Gerrit | PHIO | Common stock, $0.0001 par value | D | 126.000 | 221.281 | ||||||
| 2022-02-16 | 2022-02-15 | 4 | CAUWENBERGH GEERT | PHIO | Common stock, $0.0001 par value | D | 10.000 | 32.822 | ||||||
| 2022-02-16 | 2022-02-15 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 10.000 | 25.826 | ||||||
| 2021-08-17 | 2021-08-16 | 4 | Dispersyn Gerrit | PHIO | Common stock, $0.0001 par value | D | 1,6300 | 6.000 | 10 | 95.281 | ||||
| 2021-03-05 | 2021-03-04 | 4 | Dispersyn Gerrit | PHIO | Common stock, $0.0001 par value | D | 2,5600 | 1.953 | 5 | 89.281 | ||||
| 2021-03-03 | 2021-03-01 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 10.000 | 15.826 | ||||||
| 2021-03-03 | 2021-03-01 | 4 | Freeman Jonathan E | PHIO | Common stock, $0.0001 par value | D | 10.000 | 10.364 | ||||||
| 2021-03-03 | 2021-03-03 | 4 | Ferrara Robert L | PHIO | Common stock, $0.0001 par value | D | 3,1500 | 682 | 2 | 13.000 | ||||
| 2021-03-03 | 2021-03-01 | 4 | Ferrara Robert L | PHIO | Common stock, $0.0001 par value | D | 10.000 | 12.318 | ||||||
| 2021-03-03 | 2021-03-01 | 4 | Lockshin Curtis | PHIO | Common stock, $0.0001 par value | D | 10.000 | 10.366 | ||||||
| 2021-03-03 | 2021-03-01 | 4 | CAUWENBERGH GEERT | PHIO | Common stock, $0.0001 par value | D | 10.000 | 22.822 | ||||||
| 2021-03-03 | 2021-03-01 | 4 | Dorman H. Paul | PHIO | Common stock, $0.0001 par value | D | 10.000 | 10.370 | ||||||
| 2021-03-03 | 2021-03-03 | 4 | Dispersyn Gerrit | PHIO | Common stock, $0.0001 par value | D | 3,0300 | 2.500 | 8 | 87.328 | ||||
| 2021-03-03 | 2021-03-01 | 4 | Dispersyn Gerrit | PHIO | Common stock, $0.0001 par value | D | 68.450 | 84.828 | ||||||
| 2021-03-03 | 2021-03-01 | 4 | Kontulis Caitlin | PHIO | Common stock, $0.0001 par value | D | 34.600 | 39.826 | ||||||
| 2020-08-19 | 2020-08-19 | 4 | Dispersyn Gerrit | PHIO | Common stock, $0.0001 par value | D | 2,5000 | 2.000 | 5 | 16.377 | ||||
| 2020-03-03 | 2020-03-01 | 4 | Dispersyn Gerrit | PHIO | Common stock, $0.0001 par value | D | 2,9300 | -673 | -2 | 14.628 | ||||
| 2019-11-20 | 2019-11-18 | 4 | Kontulis Caitlin | PHIO | Common stock, $0.0001 par value | D | 0,1000 | 237.500 | 24 | 279.030 | ||||
| 2019-11-20 | 2019-11-18 | 4 | Dispersyn Gerrit | PHIO | Common stock, $0.0001 par value | D | 0,1000 | 350.000 | 35 | 827.817 | ||||
| 2019-11-20 | 2019-11-18 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 0,1000 | 300.000 | 30 | 320.440 | ||||
| 2019-11-20 | 2019-11-18 | 4 | Ferrara Robert L | PHIO | Common stock, $0.0001 par value | D | 0,1000 | 127.500 | 13 | 127.500 | ||||
| 2019-11-20 | 2019-11-18 | 4 | CAUWENBERGH GEERT | PHIO | Common stock, $0.0001 par value | D | 0,1000 | 225.000 | 22 | 704.841 | ||||
| 2019-08-02 | 2019-08-01 | 4 | Kontulis Caitlin | PHIO | Common stock, $0.0001 par value | D | 0,4030 | -749 | -0 | 41.530 | ||||
| 2019-08-02 | 2019-08-01 | 4 | Dispersyn Gerrit | PHIO | Common stock, $0.0001 par value | D | 0,4030 | -1.236 | -0 | 477.817 | ||||
| 2019-08-02 | 2019-08-01 | 4 | CAUWENBERGH GEERT | PHIO | Common stock, $0.0001 par value | D | 0,4030 | -1.751 | -1 | 479.841 | ||||
| 2019-04-24 | 2019-04-22 | 4 | Barrett John A | PHIO | Common stock, $0.0001 par value | D | 222.991 | 222.991 | ||||||
| 2019-03-05 | 2019-03-01 | 4 | Dispersyn Gerrit | PHIO | Common Stock | D | 407.703 | 479.053 | ||||||
| 2019-03-01 | 2019-02-28 | 4 | CAUWENBERGH GEERT | PHIO | Common stock, $0.0001 par value | D | 0,3798 | 152.415 | 58 | 481.592 | ||||
| 2019-02-19 | 2019-02-15 | 4 | CAUWENBERGH GEERT | PHIO | Common stock, $0.0001 par value | D | 0,3634 | 22.279 | 8 | 329.177 | ||||
| 2019-02-15 | 2019-02-13 | 4 | Dorman H. Paul | PHIO | Common stock | D | 10.000 | 20.375 | ||||||
| 2019-02-15 | 2019-02-13 | 4 | Lockshin Curtis | PHIO | Common stock | D | 10.000 | 20.130 | ||||||
| 2019-02-15 | 2019-02-13 | 4 | Freeman Jonathan E | PHIO | Common stock | D | 10.000 | 20.000 | ||||||
| 2019-02-15 | 2019-02-13 | 4 | Dispersyn Gerrit | PHIO | Common stock | D | 55.000 | 71.350 | ||||||
| 2019-02-15 | 2019-02-13 | 4 | Kontulis Caitlin | PHIO | Common stock | D | 27.000 | 40.214 | ||||||
| 2019-02-15 | 2019-02-13 | 4 | Bitterman Robert J | PHIO | Common stock | D | 10.000 | 20.440 | ||||||
| 2019-02-15 | 2019-02-13 | 4 | Brownlie Keith L | PHIO | Common stock | D | 10.000 | 20.000 | ||||||
| 2019-02-04 | 2019-02-01 | 4 | CAUWENBERGH GEERT | PHIO | Common Stock, $0.0001 par value | D | 0,3771 | 21.470 | 8 | 306.898 | ||||
| 2019-01-22 | 2019-01-18 | 4 | CAUWENBERGH GEERT | PHIO | Common stock, $0.0001 par value | D | 0,3412 | 23.729 | 8 | 285.428 | ||||
| 2019-01-07 | 2019-01-04 | 4 | CAUWENBERGH GEERT | PHIO | Common stock, $0.0001 par value | D | 0,3499 | 23.139 | 8 | 261.699 | ||||
| 2018-12-26 | 2018-12-21 | 4 | CAUWENBERGH GEERT | PHIO | Common stock, $0.0001 par value | D | 0,2950 | 27.445 | 8 | 238.560 | ||||
| 2018-12-10 | 2018-12-07 | 4 | CAUWENBERGH GEERT | PHIO | Common stock, $0.0001 par value | D | 0,3700 | 21.882 | 8 | 211.115 | ||||
| 2018-11-26 | 2018-11-23 | 4 | CAUWENBERGH GEERT | PHIO | Common stock, $0.0001 par value | D | 0,3121 | 25.941 | 8 | 189.233 | ||||
| 2018-11-13 | 2018-11-09 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,4330 | 18.698 | 8 | 163.292 | ||||
| 2018-10-29 | 2018-10-26 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,4372 | 18.519 | 8 | 144.594 | ||||
| 2018-10-15 | 2018-10-12 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,4699 | 17.230 | 8 | 126.075 | ||||
| 2018-10-01 | 2018-09-28 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 1,1700 | 73.587 | 86 | 108.845 | ||||
| 2018-08-03 | 2018-08-01 | 4 | Dorman H. Paul | RXII | Common Stock | D | 10.000 | 10.375 | ||||||
| 2018-08-03 | 2018-08-01 | 4 | Freeman Jonathan E | RXII | Common Stock | D | 10.000 | 10.000 | ||||||
| 2018-08-03 | 2018-08-01 | 4 | Lockshin Curtis | RXII | Common Stock | D | 10.000 | 10.130 | ||||||
| 2018-08-03 | 2018-08-01 | 4 | Kontulis Caitlin | RXII | Stock option (right to buy) | D | 1,79 | 10.500 | 10.500 | |||||
| 2018-08-03 | 2018-08-01 | 4 | Kontulis Caitlin | RXII | Common Stock | D | 10.500 | 11.024 | ||||||
| 2018-08-03 | 2018-08-01 | 4 | Dispersyn Gerrit | RXII | Stock option (right to buy) | D | 1,79 | 16.000 | 16.000 | |||||
| 2018-08-03 | 2018-08-01 | 4 | Dispersyn Gerrit | RXII | Common Stock | D | 16.000 | 16.350 | ||||||
| 2018-08-03 | 2018-08-01 | 4 | CAUWENBERGH GEERT | RXII | Stock option (right to buy) | D | 1,79 | 21.000 | 21.000 | |||||
| 2018-08-03 | 2018-08-01 | 4 | CAUWENBERGH GEERT | RXII | Common Stock | D | 21.000 | 35.258 | ||||||
| 2018-08-03 | 2018-08-01 | 4 | Bitterman Robert J | RXII | Common Stock | D | 10.000 | 10.440 | ||||||
| 2018-08-03 | 2018-08-01 | 4 | Brownlie Keith L | RXII | Common Stock | D | 10.000 | 10.000 | ||||||
| 2017-10-02 | 2017-10-02 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,4500 | 7.100 | 3 | 142.583 | ||||
| 2017-10-02 | 2017-10-02 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,4600 | 200 | 0 | 135.483 | ||||
| 2017-10-02 | 2017-10-02 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,4400 | 2.700 | 1 | 135.283 | ||||
| 2017-09-07 | 2017-09-07 | 4 | Eliseev Alexey | RXII | Common stock, par value $0.0001 | D | 0,5283 | -58.712 | -31 | 950.312 | ||||
| 2017-09-07 | 2017-09-06 | 4 | Eliseev Alexey | RXII | Common stock, par value $0.0001 | D | 0,5365 | -91.907 | -49 | 1.009.024 | ||||
| 2017-09-07 | 2017-09-05 | 4 | Eliseev Alexey | RXII | Common stock, par value $0.0001 | D | 0,5571 | -26.181 | -15 | 1.100.931 | ||||
| 2017-09-01 | 2017-09-01 | 4 | Eliseev Alexey | RXII | Common stock, $0.0001 par value | D | 0,5682 | -23.200 | -13 | 1.127.112 | ||||
| 2017-08-24 | 2017-08-24 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,5600 | 739 | 0 | 132.583 | ||||
| 2017-08-24 | 2017-08-24 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,5500 | 4.361 | 2 | 131.844 | ||||
| 2017-08-24 | 2017-08-24 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,5450 | 4.900 | 3 | 127.483 | ||||
| 2017-06-26 | 2017-06-23 | 4 | Dispersyn Gerrit | RXII | Common stock, $0.0001 par value | D | 0,6200 | 3.500 | 2 | 3.500 | ||||
| 2017-06-22 | 2017-06-22 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,6200 | 5.000 | 3 | 122.583 | ||||
| 2017-06-22 | 2017-06-22 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,6300 | 5.000 | 3 | 117.583 | ||||
| 2017-06-09 | 2017-06-09 | 4 | Eliseev Alexey | RXII | Series C Convertible Preferred Stock, $0.0001 par value | D | -332.499 | 0 | ||||||
| 2017-06-09 | 2017-06-09 | 4 | Eliseev Alexey | RXII | Common stock, $0.0001 par value | D | 332.499 | 1.150.312 | ||||||
| 2017-06-07 | 2017-06-06 | 4 | Freeman Jonathan E | RXII | Stock option (right to buy) | D | 0,54 | 3.500 | 3.500 | |||||
| 2017-04-26 | 2017-04-24 | 4 | Dispersyn Gerrit | RXII | Stock option (right to buy) | D | 0,65 | 95.000 | 95.000 | |||||
| 2017-04-26 | 2017-04-26 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,6480 | 10.000 | 6 | 112.583 | ||||
| 2017-03-20 | 2017-03-17 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,7655 | 15 | 0 | 102.583 | ||||
| 2017-03-20 | 2017-03-17 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,7651 | 665 | 1 | 102.568 | ||||
| 2017-03-20 | 2017-03-17 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,7695 | 9.320 | 7 | 101.903 | ||||
| 2017-02-21 | 2017-02-17 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,6950 | 2.917 | 2 | 92.583 | ||||
| 2017-02-21 | 2017-02-17 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,6924 | 6.883 | 5 | 89.666 | ||||
| 2017-02-21 | 2017-02-17 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,6915 | 200 | 0 | 82.783 | ||||
| 2017-02-08 | 2017-02-08 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,6850 | 10.000 | 7 | 82.583 | ||||
| 2017-02-03 | 2017-02-01 | 4 | CAUWENBERGH GEERT | RXII | Stock option (right to buy) | D | 0,63 | 13.000 | 13.000 | |||||
| 2017-02-03 | 2017-02-01 | 4 | Pavco Pamela | RXII | Stock option (right to buy) | D | 0,63 | 7.000 | 7.000 | |||||
| 2017-02-03 | 2017-02-01 | 4 | Bitterman Robert J | RXII | Stock option (right to buy) | D | 0,63 | 2.000 | 2.000 | |||||
| 2017-02-03 | 2017-02-01 | 4 | Brownlie Keith L | RXII | Stock option (right to buy) | D | 0,63 | 2.000 | 2.000 | |||||
| 2017-02-03 | 2017-02-01 | 4 | Lockshin Curtis | RXII | Stock option (right to buy) | D | 0,63 | 2.000 | 2.000 | |||||
| 2017-02-03 | 2017-02-01 | 4 | Kontulis Caitlin | RXII | Stock option (right to buy) | D | 0,63 | 2.500 | 2.500 | |||||
| 2017-02-03 | 2017-02-01 | 4 | Dorman H. Paul | RXII | Stock option (right to buy) | D | 0,63 | 2.000 | 2.000 | |||||
| 2017-01-26 | 2017-01-25 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,6968 | 9.700 | 7 | 72.583 | ||||
| 2017-01-26 | 2017-01-25 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,6900 | 300 | 0 | 62.883 | ||||
| 2017-01-19 | 2017-01-19 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,6949 | 600 | 0 | 62.583 | ||||
| 2017-01-19 | 2017-01-19 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,6946 | 3.000 | 2 | 61.983 | ||||
| 2017-01-19 | 2017-01-19 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,6950 | 6.400 | 4 | 58.983 | ||||
| 2017-01-17 | 3 | Eliseev Alexey | RXII | Common stock, $0.0001 par value | D | 1.635.626 | ||||||||
| 2017-01-17 | 3 | Eliseev Alexey | RXII | Common stock, $0.0001 par value | D | 1.635.626 | ||||||||
| 2017-01-03 | 2016-12-30 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,7260 | 2.000 | 1 | 52.583 | ||||
| 2016-12-27 | 2016-12-23 | 4 | CAUWENBERGH GEERT By spouse | RXII | Common stock, $0.0001 par value | I | 0,7190 | 3.000 | 2 | 4.500 | ||||
| 2016-12-23 | 2016-12-22 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,7490 | 3.000 | 2 | 53.583 | ||||
| 2016-12-20 | 2016-12-16 | 4 | Pavco Pamela | RXII | Common stock warrant | D | 0,90 | 11.111 | 11.111 | |||||
| 2016-12-20 | 2016-12-16 | 4 | Pavco Pamela | RXII | Common stock, $0.0001 par value | D | 0,9000 | 11.111 | 10 | 17.173 | ||||
| 2016-12-20 | 2016-12-16 | 4 | CAUWENBERGH GEERT | RXII | Common stock warrant | D | 0,90 | 33.333 | 33.333 | |||||
| 2016-12-20 | 2016-12-16 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,9000 | 33.333 | 30 | 50.583 | ||||
| 2016-02-12 | 2016-02-10 | 4 | Pavco Pamela | RXII | Stock option (right to buy) | D | 0,29 | 66.000 | 66.000 | |||||
| 2016-02-12 | 2016-02-10 | 4 | CAUWENBERGH GEERT | RXII | Stock option (right to buy) | D | 0,29 | 133.000 | 133.000 | |||||
| 2016-02-12 | 2016-02-10 | 4 | Bitterman Robert J | RXII | Stock option (right to buy) | D | 0,29 | 16.666 | 16.666 | |||||
| 2016-02-12 | 2016-02-10 | 4 | Brownlie Keith L | RXII | Stock option (right to buy) | D | 0,29 | 16.666 | 16.666 | |||||
| 2016-02-12 | 2016-02-10 | 4 | Lockshin Curtis | RXII | Stock option (right to buy) | D | 0,29 | 16.666 | 16.666 | |||||
| 2016-02-12 | 2016-02-10 | 4 | Kontulis Caitlin | RXII | Stock option (right to buy) | D | 0,29 | 20.000 | 20.000 | |||||
| 2016-02-12 | 2016-02-10 | 4 | Dorman H. Paul | RXII | Stock option (right to buy) | D | 0,29 | 16.666 | 16.666 | |||||
| 2015-06-23 | 2015-06-22 | 4 | CAUWENBERGH GEERT | RXII | Overallotment purchase right | D | 0,46 | -35.000 | 0 | |||||
| 2015-06-23 | 2015-06-22 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,4550 | 35.000 | 16 | 172.500 | ||||
| 2015-06-03 | 2015-06-02 | 4 | Bitterman Robert J | RXII | Overallotment purchase rights | D | 0,46 | 18.750 | 18.750 | |||||
| 2015-06-03 | 2015-06-02 | 4 | Bitterman Robert J | RXII | Common stock warrants | D | 0,52 | 18.750 | 18.750 | |||||
| 2015-06-03 | 2015-06-02 | 4 | Bitterman Robert J | RXII | Common stock, $0.0001 par value | D | 0,4000 | 37.500 | 15 | 44.000 | ||||
| 2015-06-03 | 2015-06-02 | 4 | CAUWENBERGH GEERT By spouse | RXII | Overallotment purchase right | I | 0,46 | 5.000 | 5.000 | |||||
| 2015-06-03 | 2015-06-02 | 4 | CAUWENBERGH GEERT By spouse | RXII | Common stock warrant | I | 0,52 | 5.000 | 5.000 | |||||
| 2015-06-03 | 2015-06-02 | 4 | CAUWENBERGH GEERT | RXII | Common stock warrant | D | 0,52 | 35.000 | 35.000 | |||||
| 2015-06-03 | 2015-06-02 | 4 | CAUWENBERGH GEERT | RXII | Overallotment purchase right | D | 0,46 | 35.000 | 35.000 | |||||
| 2015-06-03 | 2015-06-02 | 4 | CAUWENBERGH GEERT By spouse | RXII | Common stock, $0.0001 par value | I | 0,4000 | 10.000 | 4 | 15.000 | ||||
| 2015-06-03 | 2015-06-02 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,4000 | 70.000 | 28 | 137.500 | ||||
| 2015-06-03 | 2015-06-02 | 4 | Lockshin Curtis | RXII | Overallotment purchase right | D | 0,46 | 6.000 | 6.000 | |||||
| 2015-06-03 | 2015-06-02 | 4 | Lockshin Curtis | RXII | Common stock warrant | D | 0,52 | 6.000 | 6.000 | |||||
| 2015-06-03 | 2015-06-02 | 4 | Lockshin Curtis | RXII | Common stock, $0.0001 par value | D | 0,4000 | 12.000 | 5 | 13.000 | ||||
| 2015-06-03 | 2015-06-02 | 4 | Pavco Pamela | RXII | Common stock purchase warrant | D | 0,52 | 6.250 | 6.250 | |||||
| 2015-06-03 | 2015-06-02 | 4 | Pavco Pamela | RXII | Overallotment purchase right | D | 0,46 | 6.250 | 6.250 | |||||
| 2015-06-03 | 2015-06-02 | 4 | Pavco Pamela | RXII | Common stock, $0.0001 par value | D | 0,4000 | 12.500 | 5 | 33.718 | ||||
| 2015-06-03 | 2015-06-02 | 4 | Dorman H. Paul | RXII | Overallotment purchase right | D | 0,46 | 18.750 | 18.750 | |||||
| 2015-06-03 | 2015-06-02 | 4 | Dorman H. Paul | RXII | Common stock warrant | D | 0,52 | 18.750 | 18.750 | |||||
| 2015-06-03 | 2015-06-02 | 4 | Dorman H. Paul | RXII | Common stock, $0.0001 par value | D | 0,4000 | 37.500 | 15 | 37.500 | ||||
| 2015-06-02 | 2015-06-01 | 4 | Pavco Pamela | RXII | Stock option (right to buy) | D | 0,38 | 66.000 | 66.000 | |||||
| 2015-06-02 | 2015-06-01 | 4 | CAUWENBERGH GEERT | RXII | Stock option (right to buy) | D | 0,38 | 133.000 | 133.000 | |||||
| 2015-06-02 | 2015-06-01 | 4 | Bitterman Robert J | RXII | Stock option (right to buy) | D | 0,38 | 16.666 | 16.666 | |||||
| 2015-06-02 | 2015-06-01 | 4 | Brownlie Keith L | RXII | Stock option (right to buy) | D | 0,38 | 16.666 | 16.666 | |||||
| 2015-06-02 | 2015-06-01 | 4 | Lockshin Curtis | RXII | Stock option (right to buy) | D | 0,38 | 16.666 | 16.666 | |||||
| 2015-06-02 | 2015-06-01 | 4 | Kontulis Caitlin | RXII | Stock option (right to buy) | D | 0,38 | 10.000 | 10.000 | |||||
| 2015-06-02 | 2015-06-01 | 4 | Dorman H. Paul | RXII | Stock option (right to buy) | D | 0,38 | 16.666 | 16.666 | |||||
| 2015-04-02 | 2015-04-02 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,7192 | 5.000 | 4 | 67.500 | ||||
| 2015-02-18 | 2015-02-17 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 1,1700 | 4.000 | 5 | 62.500 | ||||
| 2015-02-11 | 2015-02-10 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 1,2499 | 1.156 | 1 | 58.500 | ||||
| 2015-02-11 | 2015-02-10 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 1,2400 | 644 | 1 | 57.344 | ||||
| 2015-02-11 | 2015-02-10 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 1,2200 | 200 | 0 | 56.700 | ||||
| 2015-01-23 | 2015-01-22 | 4 | Bitterman Robert J | RXII | Common stock, $0.0001 par value | D | 1,1900 | 1.853 | 2 | 6.500 | ||||
| 2015-01-23 | 2015-01-22 | 4 | Bitterman Robert J | RXII | Common stock, $0.0001 par value | D | 1,2000 | 3.147 | 4 | 4.647 | ||||
| 2015-01-20 | 2015-01-20 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 1,0300 | 10.000 | 10 | 56.500 | ||||
| 2014-12-31 | 2014-12-30 | 4 | CAUWENBERGH GEERT | RXII | Common Stock, $0.0001 par value | D | 1,5893 | 500 | 1 | 46.500 | ||||
| 2014-12-31 | 2014-12-30 | 4 | CAUWENBERGH GEERT | RXII | Common Stock, $0.0001 par value | D | 1,5867 | 2.000 | 3 | 46.000 | ||||
| 2014-10-14 | 2014-10-13 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 1,6799 | 3.000 | 5 | 44.000 | ||||
| 2014-09-23 | 2014-09-19 | 4 | CAUWENBERGH GEERT By child | RXII | Common stock, $0.0001 | I | 2,2000 | 4.500 | 10 | 4.500 | ||||
| 2014-09-16 | 2014-09-16 | 4 | CAUWENBERGH GEERT By Spouse | RXII | Common stock, $0.0001 par value | I | 2,0780 | 5.000 | 10 | 46.000 | ||||
| 2014-09-15 | 2014-09-15 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 2,1900 | 2.000 | 4 | 41.000 | ||||
| 2014-09-15 | 2014-09-15 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 2,1899 | 3.000 | 7 | 39.000 | ||||
| 2014-09-15 | 2014-09-15 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 2,1799 | 5.000 | 11 | 36.000 | ||||
| 2014-08-04 | 2014-07-31 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 2,4800 | 400 | 1 | 1.221.723 | ||||
| 2014-07-17 | 2014-07-15 | 4 | CAUWENBERGH GEERT | RXII | Common Stock, $0.0001 par value | D | 2,5000 | 1.000 | 2 | 31.000 | ||||
| 2014-07-09 | 2014-07-09 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 2,5699 | 1.400 | 4 | 30.000 | ||||
| 2014-07-02 | 2014-07-02 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 2,8600 | 300 | 1 | 28.600 | ||||
| 2014-07-02 | 2014-07-02 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 2,8599 | 1.000 | 3 | 28.300 | ||||
| 2014-07-02 | 2014-07-02 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 2,8500 | 700 | 2 | 27.300 | ||||
| 2014-06-26 | 2014-06-25 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,0100 | 500 | 2 | 26.600 | ||||
| 2014-06-19 | 2014-06-19 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 2,9600 | 800 | 2 | 26.100 | ||||
| 2014-06-19 | 2014-06-19 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,0000 | 200 | 1 | 25.300 | ||||
| 2014-06-19 | 2014-06-19 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 2,9921 | 1.000 | 3 | 25.100 | ||||
| 2014-06-09 | 2014-06-09 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,0499 | 800 | 2 | 24.100 | ||||
| 2014-06-09 | 2014-06-09 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,0500 | 200 | 1 | 23.300 | ||||
| 2014-06-05 | 2014-06-04 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 2,9715 | 1.000 | 3 | 23.100 | ||||
| 2014-06-05 | 2014-06-04 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 2,9140 | 1.000 | 3 | 22.100 | ||||
| 2014-06-04 | 2014-06-02 | 4 | Bitterman Robert J | RXII | Stock Option (right to buy) | D | 2,85 | 16.666 | 16.666 | |||||
| 2014-06-04 | 2014-06-02 | 4 | Brownlie Keith L | RXII | Stock Option (right to buy) | D | 2,85 | 16.666 | 16.666 | |||||
| 2014-06-04 | 2014-06-02 | 4 | Lockshin Curtis | RXII | Stock Option (right to buy) | D | 2,85 | 16.666 | 16.666 | |||||
| 2014-06-04 | 2014-06-02 | 4 | CAUWENBERGH GEERT | RXII | Stock Option (right to buy) | D | 2,85 | 133.000 | 133.000 | |||||
| 2014-06-04 | 2014-06-02 | 4 | Pavco Pamela | RXII | Stock Option (right to buy) | D | 2,85 | 66.000 | 66.000 | |||||
| 2014-06-04 | 2014-06-02 | 4 | Kontulis Caitlin | RXII | Stock Option (right to buy) | D | 2,85 | 10.000 | 10.000 | |||||
| 2014-06-04 | 2014-06-02 | 4 | Dorman H. Paul | RXII | Stock Option (right to buy) | D | 2,85 | 16.666 | 16.666 | |||||
| 2014-05-15 | 2014-04-22 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 4,1100 | -5.000 | -21 | 1.250.315 | ||||
| 2014-03-26 | 2014-03-20 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,0000 | -2.000 | -12 | 1.255.315 | ||||
| 2014-03-26 | 2014-03-12 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 5,5500 | -1.941 | -11 | 1.257.315 | ||||
| 2014-03-26 | 2014-03-12 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 5,7000 | -1.000 | -6 | 1.259.256 | ||||
| 2014-03-26 | 2014-03-12 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 5,6100 | -1.000 | -6 | 1.260.256 | ||||
| 2014-03-26 | 2014-03-12 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 5,5500 | -59 | -0 | 1.261.256 | ||||
| 2014-03-26 | 2014-03-06 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,1000 | -1.400 | -9 | 1.261.315 | ||||
| 2014-03-26 | 2014-03-06 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,1000 | -500 | -3 | 1.262.715 | ||||
| 2014-03-26 | 2014-03-06 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,1100 | -100 | -1 | 1.263.215 | ||||
| 2014-03-26 | 2014-03-05 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,0000 | -2.000 | -12 | 1.263.315 | ||||
| 2014-03-21 | 2014-02-28 | 4/A | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,2000 | -2.600 | -16 | 1.247.315 | ||||
| 2014-03-21 | 2014-02-27 | 4/A | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,1000 | -400 | -2 | 1.276.915 | ||||
| 2014-03-11 | 2014-03-04 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 5,8000 | -2.000 | -12 | 1.265.315 | ||||
| 2014-03-11 | 2014-03-04 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 5,9100 | -2.000 | -12 | 1.267.315 | ||||
| 2014-03-11 | 2014-03-03 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,1500 | -5.000 | -31 | 1.269.315 | ||||
| 2014-03-11 | 2014-02-28 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,2000 | 2.600 | 16 | 1.274.315 | ||||
| 2014-03-11 | 2014-02-27 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,1000 | 400 | 2 | 1.276.915 | ||||
| 2014-03-11 | 2014-02-27 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,1100 | -1.300 | -8 | 1.277.315 | ||||
| 2014-03-11 | 2014-02-27 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,4500 | -5.000 | -32 | 1.278.615 | ||||
| 2014-03-11 | 2014-02-26 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,0300 | -400 | -2 | 1.283.615 | ||||
| 2014-03-11 | 2014-02-25 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,5500 | -5.000 | -33 | 1.284.015 | ||||
| 2014-03-11 | 2014-02-25 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,0000 | -5.000 | -30 | 1.289.015 | ||||
| 2014-03-06 | 2014-02-24 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,3000 | -1.575 | -10 | 1.266.585 | ||||
| 2014-03-06 | 2014-02-21 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 5,0000 | -5.000 | -25 | 1.268.160 | ||||
| 2014-03-06 | 2014-02-21 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 4,8500 | -5.000 | -24 | 1.273.160 | ||||
| 2014-03-06 | 2014-02-21 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 5,1500 | -5.000 | -26 | 1.278.160 | ||||
| 2014-03-06 | 2014-02-21 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 4,8000 | -576 | -3 | 1.283.160 | ||||
| 2014-03-06 | 2014-02-21 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 4,7100 | -2.100 | -10 | 1.283.736 | ||||
| 2014-03-06 | 2014-02-21 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 4,7350 | -2.900 | -14 | 1.285.836 | ||||
| 2014-03-06 | 2014-02-21 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 4,7500 | -5.641 | -27 | 1.288.736 | ||||
| 2014-03-06 | 2014-02-20 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 4,7000 | -1.200 | -6 | 1.294.377 | ||||
| 2013-11-01 | 2013-10-31 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,1900 | 800 | 3 | 21.100 | ||||
| 2013-11-01 | 2013-10-30 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,0900 | 200 | 1 | 20.300 | ||||
| 2013-10-24 | 2013-10-23 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,3400 | 1.000 | 3 | 20.100 | ||||
| 2013-10-22 | 2013-10-22 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,4300 | 300 | 1 | 19.100 | ||||
| 2013-10-22 | 2013-10-18 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,5000 | 200 | 1 | 18.800 | ||||
| 2013-10-22 | 2013-10-18 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,3800 | 100 | 0 | 18.600 | ||||
| 2013-10-22 | 2013-10-18 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,2900 | 100 | 0 | 18.500 | ||||
| 2013-10-16 | 2013-10-16 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,5300 | 100 | 0 | 18.400 | ||||
| 2013-10-16 | 2013-10-15 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,5100 | 100 | 0 | 18.300 | ||||
| 2013-10-16 | 2013-10-14 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,5400 | 100 | 0 | 18.200 | ||||
| 2013-10-09 | 2013-10-09 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,1500 | 1.000 | 3 | 18.100 | ||||
| 2013-10-07 | 2013-10-04 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,4900 | 200 | 1 | 17.100 | ||||
| 2013-10-07 | 2013-10-03 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,5100 | 100 | 0 | 16.900 | ||||
| 2013-10-02 | 2013-09-30 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,4200 | 300 | 1 | 16.800 | ||||
| 2013-09-26 | 2013-09-26 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,5000 | 300 | 1 | 16.500 | ||||
| 2013-09-26 | 2013-09-24 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,4900 | 100 | 0 | 16.200 | ||||
| 2013-09-24 | 2013-09-23 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,4900 | 174 | 1 | 16.100 | ||||
| 2013-09-23 | 2013-09-20 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,5200 | 326 | 1 | 15.926 | ||||
| 2013-09-19 | 2013-09-18 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,4800 | 100 | 0 | 15.600 | ||||
| 2013-09-19 | 2013-09-18 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,5000 | 100 | 0 | 15.500 | ||||
| 2013-09-17 | 2013-09-17 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,5500 | 200 | 1 | 15.400 | ||||
| 2013-09-16 | 2013-09-13 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,6000 | 100 | 0 | 15.200 | ||||
| 2013-09-16 | 2013-09-13 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,5500 | 100 | 0 | 15.100 | ||||
| 2013-09-12 | 2013-09-11 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,5500 | 150 | 1 | 15.000 | ||||
| 2013-09-12 | 2013-09-10 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,5800 | 150 | 1 | 14.850 | ||||
| 2013-09-12 | 2013-09-10 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,6500 | 200 | 1 | 14.700 | ||||
| 2013-09-03 | 2013-08-30 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,3500 | 200 | 1 | 14.500 | ||||
| 2013-09-03 | 2013-08-30 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,3800 | 100 | 0 | 14.300 | ||||
| 2013-08-30 | 2013-08-29 | 4 | Lockshin Curtis | RXII | Common stock, $0.0001 par value | D | 3,7000 | 1.000 | 4 | 1.000 | ||||
| 2013-08-30 | 2013-08-29 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,5500 | 200 | 1 | 14.200 | ||||
| 2013-08-30 | 2013-08-29 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,4000 | 200 | 1 | 14.000 | ||||
| 2013-08-29 | 2013-08-28 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,7000 | 100 | 0 | 13.800 | ||||
| 2013-08-29 | 2013-08-28 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,6000 | 100 | 0 | 13.700 | ||||
| 2013-08-29 | 2013-08-28 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,7500 | 200 | 1 | 13.600 | ||||
| 2013-08-28 | 2013-08-27 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,7000 | 100 | 0 | 13.400 | ||||
| 2013-08-27 | 2013-08-26 | 4 | Bitterman Robert J | RXII | Common stock, $0.0001 par value | D | 3,9000 | 500 | 2 | 1.500 | ||||
| 2013-08-26 | 2013-08-23 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,6900 | 200 | 1 | 13.300 | ||||
| 2013-08-26 | 2013-08-23 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,7500 | 100 | 0 | 13.100 | ||||
| 2013-08-23 | 2013-08-22 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,6200 | 300 | 1 | 13.000 | ||||
| 2013-08-22 | 2013-08-21 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,8000 | 680 | 3 | 12.700 | ||||
| 2013-08-21 | 2013-08-20 | 4 | CAUWENBERGH GEERT | RXII | Common Stock, $0.0001 par value | D | 3,7500 | 200 | 1 | 12.020 | ||||
| 2013-08-21 | 2013-08-20 | 4 | CAUWENBERGH GEERT | RXII | Common Stock, $0.0001 par value | D | 3,7000 | 200 | 1 | 11.820 | ||||
| 2013-08-21 | 2013-08-20 | 4 | CAUWENBERGH GEERT | RXII | Common Stock, $0.0001 par value | D | 3,9000 | 300 | 1 | 11.620 | ||||
| 2013-08-20 | 2013-08-19 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,6500 | 100 | 0 | 11.320 | ||||
| 2013-08-20 | 2013-08-19 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,6700 | 120 | 0 | 11.220 | ||||
| 2013-08-20 | 2013-08-19 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,8600 | 100 | 0 | 11.100 | ||||
| 2013-08-06 | 2013-08-06 | 4 | CAUWENBERGH GEERT | RXII | Common stock, par value $0.0001 | D | 4,0500 | 350 | 1 | 11.000 | ||||
| 2013-08-06 | 2013-08-05 | 4 | CAUWENBERGH GEERT | RXII | Common stock, par value $0.0001 | D | 4,0300 | 150 | 1 | 10.650 | ||||
| 2013-08-06 | 2013-08-05 | 4 | CAUWENBERGH GEERT | RXII | Common stock, par value $0.0001 | D | 4,0000 | 500 | 2 | 10.500 | ||||
| 2013-08-05 | 2013-08-05 | 4 | Bitterman Robert J | RXII | Common stock, par value $0.0001 | D | 4,0500 | 100 | 0 | 1.000 | ||||
| 2013-08-05 | 2013-08-05 | 4 | Bitterman Robert J | RXII | Common stock, par value $0.0001 | D | 4,0200 | 100 | 0 | 900 | ||||
| 2013-08-05 | 2013-08-05 | 4 | Bitterman Robert J | RXII | Common stock, par value $0.0001 | D | 4,0100 | 100 | 0 | 800 | ||||
| 2013-08-05 | 2013-08-05 | 4 | Bitterman Robert J | RXII | Common stock, par value $0.0001 | D | 4,0500 | 200 | 1 | 700 | ||||
| 2013-08-05 | 2013-08-05 | 4 | Bitterman Robert J | RXII | Common stock, par value $0.0001 | D | 4,1300 | 500 | 2 | 500 | ||||
| 2013-07-31 | 2013-07-31 | 4 | CAUWENBERGH GEERT | RXII | Common stock, par value $0.0001 | D | 4,1000 | 500 | 2 | 9.833 | ||||
| 2013-07-31 | 2013-07-31 | 4 | CAUWENBERGH GEERT | RXII | Common stock, par value $0.0001 | D | 4,0200 | 167 | 1 | 10.000 | ||||
| 2013-07-31 | 2013-07-23 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1580 | -28.000 | -4 | 38.820.446 | ||||
| 2013-07-30 | 2013-07-29 | 4 | CAUWENBERGH GEERT | RXII | Common stock, par value $0.0001 | D | 4,5400 | 500 | 2 | 9.333 | ||||
| 2013-07-29 | 2013-07-26 | 4 | CAUWENBERGH GEERT | RXII | Common stock, par value $0.0001 | D | 4,8700 | 500 | 2 | 8.833 | ||||
| 2013-07-22 | 2013-07-19 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1490 | -111.684 | -17 | 38.918.656 | ||||
| 2013-07-22 | 2013-07-18 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1535 | -100.000 | -15 | 38.960.130 | ||||
| 2013-07-22 | 2013-07-18 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1525 | -100.000 | -15 | 39.060.130 | ||||
| 2013-07-22 | 2013-07-17 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1600 | -100.000 | -16 | 39.160.130 | ||||
| 2013-07-15 | 2013-07-11 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1980 | -95.000 | -19 | 39.260.130 | ||||
| 2013-07-15 | 2013-07-11 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1990 | -5.000 | -1 | 39.355.130 | ||||
| 2013-07-15 | 2013-07-10 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1950 | -100.000 | -20 | 39.360.130 | ||||
| 2013-07-15 | 2013-07-10 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1950 | -100.000 | -20 | 39.360.130 | ||||
| 2013-07-15 | 2013-07-10 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1960 | -30.000 | -6 | 39.560.130 | ||||
| 2013-07-08 | 2013-07-05 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1950 | -18.180 | -4 | 39.590.130 | ||||
| 2013-07-08 | 2013-07-05 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1940 | -100.000 | -19 | 39.608.310 | ||||
| 2013-07-08 | 2013-07-03 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1945 | -50.000 | -10 | 39.708.310 | ||||
| 2013-07-08 | 2013-07-03 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1930 | -50.000 | -10 | 39.758.310 | ||||
| 2013-07-03 | 2013-07-02 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1930 | -30.000 | -6 | 39.808.310 | ||||
| 2013-07-03 | 2013-07-02 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1970 | -9.249 | -2 | 39.838.310 | ||||
| 2013-07-03 | 2013-07-01 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1970 | -50.000 | -10 | 39.847.559 | ||||
| 2013-07-03 | 2013-07-01 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1965 | -50.000 | -10 | 39.897.559 | ||||
| 2013-07-02 | 2013-06-28 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1980 | -46.874 | -9 | 39.947.559 | ||||
| 2013-07-02 | 2013-06-27 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1930 | -45.000 | -9 | 39.994.433 | ||||
| 2013-07-02 | 2013-06-27 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1930 | -60.000 | -12 | 40.039.433 | ||||
| 2013-07-02 | 2013-06-27 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1980 | -50.000 | -10 | 40.099.433 | ||||
| 2013-07-02 | 2013-06-26 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1980 | -25.500 | -5 | 40.149.433 | ||||
| 2013-07-02 | 2013-06-26 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1950 | -50.000 | -10 | 40.174.933 | ||||
| 2013-07-02 | 2013-06-25 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1940 | -50.000 | -10 | 40.224.933 | ||||
| 2013-06-11 | 2013-06-07 | 4 | CAUWENBERGH GEERT | RXII | Stock Option (right to buy) | D | 0,20 | 4.000.000 | 4.000.000 | |||||
| 2013-06-11 | 2013-06-07 | 4 | Pavco Pamela | RXII | Stock Option (right to buy) | D | 0,20 | 2.000.000 | 2.000.000 | |||||
| 2013-06-11 | 2013-06-07 | 4 | Bitterman Robert J | RXII | Stock Option (right to buy) | D | 0,20 | 500.000 | 500.000 | |||||
| 2013-06-11 | 2013-06-07 | 4 | Brownlie Keith L | RXII | Stock Option (right to buy) | D | 0,20 | 500.000 | 500.000 | |||||
| 2013-06-11 | 2013-06-07 | 4 | Kontulis Caitlin | RXII | Stock Option (right to buy) | D | 0,20 | 300.000 | 300.000 | |||||
| 2013-05-03 | 2013-04-18 | 4/A | Lockshin Curtis | RXII | Stock Option (right to buy) | D | 0,24 | 1.000.000 | 1.000.000 | |||||
| 2013-05-03 | 2013-04-18 | 4/A | Dorman H. Paul | RXII | Stock Option (right to buy) | D | 0,24 | 1.000.000 | 1.000.000 | |||||
| 2013-05-02 | 2013-05-02 | 4 | Galena Biopharma, Inc. | RXII | Common Stock, $0.0001 par value | D | 0,1905 | -253.000 | -48 | 32.393.095 | ||||
| 2013-05-02 | 2013-05-01 | 4 | Galena Biopharma, Inc. | RXII | Common Stock, $0.0001 par value | D | 0,1925 | -659.500 | -127 | 32.646.095 | ||||
| 2013-05-02 | 2013-04-30 | 4 | Galena Biopharma, Inc. | RXII | Common Stock, $0.0001 par value | D | 0,2138 | -171.000 | -37 | 33.305.595 | ||||
| 2013-04-23 | 2013-03-18 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,3480 | -52.900 | -18 | 39.831.365 | ||||
| 2013-04-23 | 2013-03-15 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,3250 | -100.000 | -32 | 39.884.265 | ||||
| 2013-04-23 | 2013-03-14 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,3310 | -126.843 | -42 | 39.984.265 | ||||
| 2013-04-23 | 2013-03-14 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,3340 | -7.500 | -3 | 40.111.108 | ||||
| 2013-04-23 | 2013-03-12 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,2720 | -100.000 | -27 | 40.118.608 | ||||
| 2013-04-23 | 2013-03-11 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,2730 | -100.000 | -27 | 40.218.608 | ||||
| 2013-04-23 | 2013-03-11 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,2210 | -100.000 | -22 | 40.318.608 | ||||
| 2013-04-23 | 2013-03-11 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,2400 | -100.000 | -24 | 40.418.608 | ||||
| 2013-04-23 | 2013-03-11 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,2330 | -100.000 | -23 | 40.518.608 | ||||
| 2013-04-23 | 2013-03-08 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1940 | -50.000 | -10 | 40.618.608 | ||||
| 2013-04-23 | 2013-03-07 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1950 | -50.000 | -10 | 40.668.608 | ||||
| 2013-04-23 | 2013-03-06 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1490 | -36.570 | -5 | 40.718.608 | ||||
| 2013-04-23 | 2013-03-05 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1450 | -30.000 | -4 | 40.755.178 | ||||
| 2013-04-23 | 2013-03-04 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 | D | 0,1450 | -50.000 | -7 | 40.785.178 | ||||
| 2013-04-23 | 2013-03-01 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 | D | 0,1500 | -20.000 | -3 | 40.835.178 | ||||
| 2013-04-23 | 2013-02-28 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1600 | -200 | -0 | 40.855.178 | ||||
| 2013-04-23 | 2013-02-27 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1600 | -29.888 | -5 | 40.855.378 | ||||
| 2013-04-23 | 2013-02-26 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1750 | -4.000 | -1 | 40.885.266 | ||||
| 2013-04-23 | 2013-02-25 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1820 | -8.000 | -1 | 40.889.266 | ||||
| 2013-04-23 | 2013-02-25 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1800 | -92.000 | -17 | 40.897.266 | ||||
| 2013-04-23 | 2013-02-22 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1600 | -40.000 | -6 | 40.989.266 | ||||
| 2013-04-23 | 2013-02-19 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1920 | -1.000 | -0 | 41.029.266 | ||||
| 2013-04-23 | 2013-02-19 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1900 | -49.000 | -9 | 41.030.266 | ||||
| 2013-04-23 | 2013-02-15 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1360 | -40.000 | -5 | 41.079.266 | ||||
| 2013-04-23 | 2013-02-14 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1160 | -30.000 | -3 | 41.119.266 | ||||
| 2013-04-23 | 2013-02-11 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,0910 | -20.000 | -2 | 41.149.266 | ||||
| 2013-04-23 | 2013-02-11 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,0950 | -20.000 | -2 | 41.169.266 | ||||
| 2013-04-23 | 2013-02-11 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1150 | -40.000 | -5 | 41.189.266 | ||||
| 2013-04-23 | 2013-02-06 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,0860 | -20.000 | -2 | 41.229.266 | ||||
| 2013-04-23 | 2013-02-05 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,0760 | -10.000 | -1 | 41.249.266 | ||||
| 2013-04-23 | 2013-03-21 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,2320 | -48.500 | -11 | 39.684.265 | ||||
| 2013-04-23 | 2013-03-20 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,2310 | -57.100 | -13 | 39.732.765 | ||||
| 2013-04-23 | 2013-03-20 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,2550 | -1.500 | -0 | 39.789.865 | ||||
| 2013-04-23 | 2013-03-19 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,3000 | -40.000 | -12 | 39.791.365 | ||||
| 2013-04-22 | 2013-04-18 | 4 | Lockshin Curtis | RXII | Stock Option (right to buy) | D | 0,24 | 1.000.000 | 1.000.000 | |||||
| 2013-04-22 | 2013-04-18 | 4 | Dorman H. Paul | RXII | Stock Option (right to buy) | D | 0,24 | 1.000.000 | 1.000.000 | |||||
| 2013-03-19 | 3 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 41.259.266 | ||||||||
| 2013-03-13 | 3 | Opko Health, Inc. | RXII | Common Stock | D | 67.241.380 | ||||||||
| 2013-03-08 | 2013-03-06 | 4 | CAUWENBERGH GEERT | RXII | Common Stock | D | 0,1450 | 250.000 | 36 | 250.000 | ||||
| 2013-03-01 | 3 | Pavco Pamela | RXII | Common stock, par value $0.0001 | D | 90.153 | ||||||||
| 2013-03-01 | 3 | Galena Biopharma, Inc. | RXII | Common stock, $0.0001 par value | D | 33.476.595 | ||||||||
| 2013-03-01 | 3 | Kontulis Caitlin | RXII | Common stock, par value $0.0001 | D | 2.231 |
P
Offener Markt oder privater Kauf von nicht-derivativen oder derivativen Wertpapieren
S
Freiverkauf oder privater Verkauf von nicht-derivativen oder derivativen Wertpapieren
A
Gewährung, Vergabe oder sonstiger Erwerb von Wertpapieren des Unternehmens (z. B. eine Option)
C
Umwandlung von Derivaten
D
Verkauf oder Rückübertragung von Wertpapieren an das Unternehmen
F
Zahlung des Ausübungspreises oder der Steuerschuld mit einem Teil der vom Unternehmen erhaltenen Wertpapiere
G
Schenkung von Wertpapieren durch oder an den Insider
K
Aktien-Swaps und ähnliche Absicherungstransaktionen
M
Ausübung oder Umwandlung eines vom Unternehmen erhaltenen derivativen Wertpapiers (z. B. einer Option)
V
Eine freiwillig auf Formular 4 gemeldete Transaktion
J
Sonstige (mit einer Fußnote zur Beschreibung der Transaktion)
